8/29/19 17:03 | 8/27/19 | CERC | Cerecor Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pedder Simon | MD | DO | Exec CB | P.d | 20 | 2.98 | 0 | 7 | 3 | 263 | D | | | | | | | | | | | | | | |
5/16/19 16:19 | 5/14/19 | CERC | Cerecor Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pedder Simon | MD | DO | Exec CB | P.d | 30 | 5.06 | 0 | 6 | New | 6 | D | | | | | | | | | | | | | | |
11/14/18 18:10 | 11/14/18 | ATNX | Athenex, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pedder Simon | NY | O | See Rema | P.d | 30 | 10.26 | 0 | 3 | 291 | 4 | D | | | | | | | | | | | | | | |
7/28/17 16:30 | 6/19/17 | ATNX | Athenex, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pedder Simon | NY | O | See Rema | P.a | 11 | 11.00 | 0 | 1 | New | 1 | D | | | | | | | | | | | | | | |
8/22/14 16:38 | 8/20/14 | CLRB | Cellectar Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pedder Simon | WI | DO | P,CEO | P.d | 50 | 3.75 | 0 | 13 | New | 13 | D | -86 | -63 | -64 | -55 | -55 | -57 | -39 | -3 | 4 | 7 | -16 | -14 | -9 | 0 |
9/7/10 08:22 | 9/2/10 | CHTP | Chelsea Therapeutics International, Ltd. | DE | Health | BioPrd | Biological Products, (No Diag | Pedder Simon | NC | DO | CEO | P.d | 5 | 4.08 | 2 | 1 | 0 | 488 | D | -11 | -25 | 38 | 36 | 31 | 27 | 1 | 0 | -2 | -1 | 36 | 33 | -4 | 0 |
12/21/09 14:27 | 12/17/09 | CHTP | Chelsea Therapeutics International, Ltd. | DE | Health | BioPrd | Biological Products, (No Diag | Pedder Simon | NC | DO | CEO | P.d | 10 | 2.20 | 1 | 5 | 1 | 487 | D | -66 | 85 | -52 | -70 | -3 | -2 | -4 | -4 | 4 | 20 | 33 | 84 | 46 | 254 |
9/24/08 16:20 | 9/24/08 | CHTP | Chelsea Therapeutics International, Ltd. | DE | Health | BioPrd | Biological Products, (No Diag | Pedder Simon | NC | DO | CEO | P.d | 9 | 2.91 | 0 | 3 | 1 | 482 | D | -8 | -53 | -41 | -46 | -46 | -37 | -35 | -5 | 14 | 15 | -11 | -56 | -42 | 143 |
8/24/06 14:54 | 8/23/06 | CHTP | Chelsea Therapeutics International, Ltd. | DE | Health | BioPrd | Biological Products, (No Diag | Pedder Simon | NC | DO | CEO | P.d | 3 | 3.27 | 0 | 1 | 0 | 479 | D | | | -35 | -23 | -13 | -8 | -2 | 2 | 1 | -1 | 9 | 29 | 80 | 71 |